Dogra S, Adhikari L, Benbrook DM, Bohn JA, Burgett A, Chandra V, Dockery L, Singh A, McNally L, Rai R, Isingizwe ZR, Richardson DL, Yang Z, Hannafon BN. Harnessing ovarian cancer ascites for translational science: models, biomarkers, and therapeutics. Mol Cancer. 2025 Oct 14;24(1):257. doi: 10.1186/s12943-025-02438-z. PMID: 41088281; PMCID: PMC12522915. https://link.springer.com/article/10.1186/s12943-025-02438-z
Bhandari K, Kong JS, Tanaka T, Dooley WC, Xu C, Hannafon BN, Ding WQ. Exosome-Associated MTA1 in Circulation Is Elevated During Breast Cancer Progression. FASEB J. 2025 Jul 31;39(14):e70872. doi: 10.1096/fj.202500221R. PMID: 40716099; PMCID: PMC12704216. https://faseb.onlinelibrary.wiley.com/doi/10.1096/fj.202500221R
Mohammed S, Jiang C, Pennington T, Bhaskaran S, Ohene-Marfo P, Georgescu C, Pitts K, Tran A, Peng Z, Singh A, Yang Z, Li T, Hannafon B, Houchen C, Wren JD, Galvan V, Ahsan N, Kinter M, Lewis TL, Deepa SS. A Non-canonical Role for Hepatocyte MLKL in Promoting Mitochondrial Dysfunction and Senescence in the Aging Liver. bioRxiv [Preprint]. 2025 May 3:2025.05.02.651782. doi: 10.1101/2025.05.02.651782. PMID: 40654837; PMCID: PMC12247894. https://www.biorxiv.org/content/10.1101/2025.05.02.651782v1
Elayapillai SP, Dogra S, Hladik C, Lausen J, Bruns M, Gossett AG, Behbod F, Xu C, Zhang R, Ding WQ, Hannafon BN. Preferential release of microRNAs via extracellular vesicles is associated with ductal carcinoma in situ to invasive breast cancer progression. Cancer Lett. 2025 Aug 10;625:217794. doi: 10.1016/j.canlet.2025.217794. Epub 2025 May 17. PMID: 40389020. https://www.sciencedirect.com/science/article/pii/S0304383525003611?via%3Dihub
Figueroa-Hall LK, Burrows K, Alarbi AM, Hannafon BN, Hladik C, Tan C, Ramesh R, Stewart JL, Risbrough VB, Paulus MP, Teague TK. Comparison of Methods for Isolation and Characterization of Total and Astrocyte-Enriched Extracellular Vesicles From Human Serum and Plasma. J Extracell Biol. 2025 Feb 14;4(2):e70035. doi: 10.1002/jex2.70035. PMID: 39958973; PMCID: PMC11826443.https://isevjournals.onlinelibrary.wiley.com/doi/10.1002/jex2.70035
Elayapillai SP, Gandhi A, Dogra S, Saunders D, Smith N, Hladik C, Towner RA, Moxley KM, Hannafon BN. Oklahoma nitrone-007 is an effective anticancer therapeutic agent targeting inflammatory and immune metabolism pathways in endometrial cancer. J Pharmacol Exp Ther. 2025 Jan;392(1):100004. doi: 10.1124/jpet.124.002223. Epub 2024 Nov 22. PMID: 39893009; PMCID: PMC13095626.https://www.sciencedirect.com/science/article/pii/S0022356524000235?via%3Dihub
Xu, Y. F., Xu, X., Gin, A., Nshimiyimana, J. D., Mooers, B. H. M., Caputi, M., Hannafon, B. N., & Ding, W. Q. (2020). SRSF1 regulates exosome microRNA enrichment in human cancer cells. Cell Commun Signal, 18(1), 130. https://doi.org/10.1186/s12964-020-00615-9
Xu, Y. F., Hannafon, B. N., Khatri, U., Gin, A., & Ding, W. Q. (2019). The origin of exosomal miR-1246 in human cancer cells. RNA Biol, 16(6), 770-784.
Hannafon, B. N., Gin, A. L., Xu, Y. F., Bruns, M., Calloway, C. L., & Ding, W. Q. (2019). Metastasis-associated protein 1 (MTA1) is transferred by exosomes and contributes to the regulation of hypoxia and estrogen signaling in breast cancer cells. Cell Commun Signal, 17(1), 13. https://doi.org/10.1186/s12964-019-0325-7
Hannafon, B. N., & Ding, W. Q. (2019). Functional Role of miRNAs in the Progression of Breast Ductal Carcinoma in Situ. Am J Pathol, 189(5), 966-974. https://doi.org/10.1016/j.ajpath.2018.06.025
Hannafon, B. N., Cai, A., Calloway, C. L., Xu, Y. F., Zhang, R., Fung, K. M., & Ding, W. Q. (2019). miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study. BMC Cancer, 19(1), 642. https://doi.org/10.1186/s12885-019-5839-2
Hannafon, B. N., & Ding, W. Q. (2018). miRNAs as Biomarkers for Predicting the Progression of Ductal Carcinoma in Situ. Am J Pathol, 188(3), 542-549. https://doi.org/10.1016/j.ajpath.2017.11.003
Jiao, Y., Watts, T., Xue, J., Hannafon, B., & Ding, W. Q. (2018). Sorafenib and docosahexaenoic acid act in synergy to suppress cancer cell viability: a role of heme oxygenase 1. BMC Cancer, 18(1), 1042. https://doi.org/10.1186/s12885-018-4946-9
Xu, Y. F., Hannafon, B. N., Zhao, Y. D., Postier, R. G., & Ding, W. Q. (2017). Plasma exosome miR-196a and miR-1246 are potential indicators of localized pancreatic cancer. Oncotarget, 8(44), 77028-77040. https://doi.org/10.18632/oncotarget.20332
Xu, Y. F., Hannafon, B. N., & Ding, W. Q. (2017). microRNA regulation of human pancreatic cancer stem cells. Stem Cell Investig, 4, 5. https://doi.org/10.21037/sci.2017.01.01
Jiao, Y., Hannafon, B. N., Zhang, R. R., Fung, K. M., & Ding, W. Q. (2017). Docosahexaenoic acid and disulfiram act in concert to kill cancer cells: a mutual enhancement of their anticancer actions. Oncotarget, 8(11), 17908-17920. https://doi.org/10.18632/oncotarget.14702
Jiao, Y., Hannafon, B. N., & Ding, W. Q. (2016). Disulfiram's Anticancer Activity: Evidence and Mechanisms. Anticancer Agents Med Chem, 16(11), 1378-1384. https://doi.org/10.2174/1871520615666160504095040
Hannafon, B. N., Trigoso, Y. D., Calloway, C. L., Zhao, Y. D., Lum, D. H., Welm, A. L., Zhao, Z. J., Blick, K. E., Dooley, W. C., & Ding, W. Q. (2016). Plasma exosome microRNAs are indicative of breast cancer. Breast Cancer Res, 18(1), 90. https://doi.org/10.1186/s13058-016-0753-x
Wang, S., Hannafon, B. N., Lind, S. E., & Ding, W. Q. (2015). Zinc Protoporphyrin Suppresses β-Catenin Protein Expression in Human Cancer Cells: The Potential Involvement of Lysosome-Mediated Degradation. PLoS One, 10(5), e0127413. https://doi.org/10.1371/journal.pone.0127413
Hannafon, B. N., & Ding, W. Q. (2015). Cancer stem cells and exosome signaling. Stem Cell Investig, 2, 11. https://doi.org/10.3978/j.issn.2306-9759.2015.05.02
Hannafon, B. N., Carpenter, K. J., Berry, W. L., Janknecht, R., Dooley, W. C., & Ding, W. Q. (2015). Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA). Mol Cancer, 14, 133. https://doi.org/10.1186/s12943-015-0400-7
Zhang, S., Xue, J., Zheng, J., Wang, S., Zhou, J., Jiao, Y., Geng, Y., Wu, J., Hannafon, B. N., & Ding, W. Q. (2015). The superoxide dismutase 1 3'UTR maintains high expression of the SOD1 gene in cancer cells: The involvement of the RNA-binding protein AUF-1. Free Radic Biol Med, 85, 33-44. https://doi.org/10.1016/j.freeradbiomed.2015.04.012
Xue, J., Moyer, A., Peng, B., Wu, J., Hannafon, B. N., & Ding, W. Q. (2014). Chloroquine is a zinc ionophore. PLoS One, 9(10), e109180. https://doi.org/10.1371/journal.pone.0109180
Wang, S., Hannafon, B. N., Wolf, R. F., Zhou, J., Avery, J. E., Wu, J., Lind, S. E., & Ding, W. Q. (2014). Characterization of docosahexaenoic acid (DHA)-induced heme oxygenase-1 (HO-1) expression in human cancer cells: the importance of enhanced BTB and CNC homology 1 (Bach1) degradation. J Nutr Biochem, 25(5), 515-525. https://doi.org/10.1016/j.jnutbio.2013.12.011
Xue, J., Wang, S., Wu, J., Hannafon, B. N., & Ding, W. Q. (2013). Zinc at sub-cytotoxic concentrations induces heme oxygenase-1 expression in human cancer cells. Cell Physiol Biochem, 32(1), 100-110. https://doi.org/10.1159/000350128
Wang, S., Avery, J. E., Hannafon, B. N., Lind, S. E., & Ding, W. Q. (2013). Zinc protoporphyrin suppresses cancer cell viability through a heme oxygenase-1-independent mechanism: the involvement of the Wnt/β-catenin signaling pathway. Biochem Pharmacol, 85(11), 1611-1618. https://doi.org/10.1016/j.bcp.2013.03.011
Hannafon, B. N., & Ding, W. Q. (2013). Intercellular communication by exosome-derived microRNAs in cancer. Int J Mol Sci, 14(7), 14240-14269. https://doi.org/10.3390/ijms140714240
Wang, S., Hannafon, B. N., Zhou, J., & Ding, W. Q. (2013). Clofibrate induces heme oxygenase 1 expression through a PPARα-independent mechanism in human cancer cells. Cell Physiol Biochem, 32(5), 1255-1264. https://doi.org/10.1159/000354524
Hannafon, B. N., Sebastiani, P., de las Morenas, A., Lu, J., & Rosenberg, C. L. (2011). Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer. Breast Cancer Res, 13(2), R24. https://doi.org/10.1186/bcr2839
Liu, T., Hannafon, B., Gill, L., Kelly, W., & Benbrook, D. (2007). Flex-Hets differentially induce apoptosis in cancer over normal cells by directly targeting mitochondria. Mol Cancer Ther, 6(6), 1814-1822. https://doi.org/10.1158/1535-7163.Mct-06-0279
Benbrook, D. M., Kamelle, S. A., Guruswamy, S. B., Lightfoot, S. A., Rutledge, T. L., Gould, N. S., Hannafon, B. N., Dunn, S. T., & Berlin, K. D. (2005). Flexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonists. Invest New Drugs, 23(5), 417-428. https://doi.org/10.1007/s10637-005-2901-5